+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
ID07801274

Observational Study of Postoperative Edge RapidArc Stereotactic Body Radiotherapy for Patients with Spinal Metastases from Solid Tumors

Led by Tianjin Medical University Cancer Institute and Hospital · Updated on 2026-09-03

50

Participants Needed

1

Research Sites

82 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the outcomes of high-precision postoperative stereotactic body radiotherapy SBRT using the Edge system for patients with spinal metastases from solid tumors. Spinal metastases can compress the spinal cord, causing pain, weakness, or paralysis. This observational study aims to assess whether this precise radiation treatment improves local tumor control, neurological function, reduces treatment time, and enhances quality of life. Participants receive postoperative SBRT with the Edge system, which delivers a total radiation dose of 35 Gy divided into 5 sessions 7 Gy each. The Edge system provides sub-millimeter accuracy with advanced positioning and surface monitoring to target tumors while protecting the spinal cord. The study observes patients for up to two years following treatment to evaluate various clinical outcomes. During the study, researchers will collect data on tumor control at 3 months, neurological status, survival rates, quality of life assessments, and any adverse effects such as radiation-related myelitis or esophagitis. Assessments occur at baseline, 3 months, 1 year, and 2 years post-treatment. The study will analyze these outcomes to understand the effectiveness and safety of this radiation approach, with participation lasting until the studys completion in 2028.

CONDITIONS

Brief Title

Postoperative Edge (RapidArc) Stereotactic Body Radiotherapy for Spinal Metastases

Research Team

X

Xu Liming, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here